448 related articles for article (PubMed ID: 34684520)
1. Metabolic Syndrome and Sarcopenia.
Nishikawa H; Asai A; Fukunishi S; Nishiguchi S; Higuchi K
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684520
[TBL] [Abstract][Full Text] [Related]
2. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.
Buch A; Carmeli E; Boker LK; Marcus Y; Shefer G; Kis O; Berner Y; Stern N
Exp Gerontol; 2016 Apr; 76():25-32. PubMed ID: 26785313
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia.
Tournadre A; Vial G; Capel F; Soubrier M; Boirie Y
Joint Bone Spine; 2019 May; 86(3):309-314. PubMed ID: 30098424
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.
Kalinkovich A; Livshits G
Ageing Res Rev; 2017 May; 35():200-221. PubMed ID: 27702700
[TBL] [Abstract][Full Text] [Related]
5. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
Biolo G; Cederholm T; Muscaritoli M
Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
[TBL] [Abstract][Full Text] [Related]
6. The decline in muscle strength and muscle quality in relation to metabolic derangements in adult women with obesity.
Poggiogalle E; Lubrano C; Gnessi L; Mariani S; Di Martino M; Catalano C; Lenzi A; Donini LM
Clin Nutr; 2019 Oct; 38(5):2430-2435. PubMed ID: 30792144
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenic obesity: molecular clues to a better understanding of its pathogenesis?
Kob R; Bollheimer LC; Bertsch T; Fellner C; Djukic M; Sieber CC; Fischer BE
Biogerontology; 2015 Feb; 16(1):15-29. PubMed ID: 25376109
[TBL] [Abstract][Full Text] [Related]
8. Novel effects of sarcopenic osteoarthritis on metabolic syndrome, insulin resistance, osteoporosis, and bone fracture: the national survey.
Chung SM; Hyun MH; Lee E; Seo HS
Osteoporos Int; 2016 Aug; 27(8):2447-57. PubMed ID: 27177746
[TBL] [Abstract][Full Text] [Related]
9. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.
Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V
Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenic obesity: Time to meet the challenge.
Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
[TBL] [Abstract][Full Text] [Related]
11. The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.
Consitt LA; Clark BC
J Frailty Aging; 2018; 7(1):21-27. PubMed ID: 29412438
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.
Cleasby ME; Jamieson PM; Atherton PJ
J Endocrinol; 2016 May; 229(2):R67-81. PubMed ID: 26931135
[TBL] [Abstract][Full Text] [Related]
13. Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention.
Li CW; Yu K; Shyh-Chang N; Li GX; Jiang LJ; Yu SL; Xu LY; Liu RJ; Guo ZJ; Xie HY; Li RR; Ying J; Li K; Li DJ
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):586-600. PubMed ID: 30969486
[TBL] [Abstract][Full Text] [Related]
14. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
15. Frailty and sarcopenia as the basis for the phenotypic manifestation of chronic diseases in older adults.
Angulo J; El Assar M; Rodríguez-Mañas L
Mol Aspects Med; 2016 Aug; 50():1-32. PubMed ID: 27370407
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and mechanisms of primary sarcopenia (Review).
Nishikawa H; Fukunishi S; Asai A; Yokohama K; Nishiguchi S; Higuchi K
Int J Mol Med; 2021 Aug; 48(2):. PubMed ID: 34184088
[TBL] [Abstract][Full Text] [Related]
17. Testosterone Deficiency and Testosterone Treatment in Older Men.
Saad F; Röhrig G; von Haehling S; Traish A
Gerontology; 2017; 63(2):144-156. PubMed ID: 27855417
[TBL] [Abstract][Full Text] [Related]
18. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010.
Moon SS
Endocr J; 2014; 61(1):61-70. PubMed ID: 24088600
[TBL] [Abstract][Full Text] [Related]
19. Associations of Sarcopenia and Sarcopenic Obesity With Metabolic Syndrome Considering Both Muscle Mass and Muscle Strength.
Lee J; Hong YP; Shin HJ; Lee W
J Prev Med Public Health; 2016 Jan; 49(1):35-44. PubMed ID: 26841883
[TBL] [Abstract][Full Text] [Related]
20. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
